183 related articles for article (PubMed ID: 8824551)
21. mRNA levels of molecular chaperones hsp27, hsp60 and hsp70 in cisplatin resistant squamous cell carcinomas.
Nakata B; Hom D; Barton R; Howell S; Los G
Int J Oncol; 1996 Jun; 8(6):1229-35. PubMed ID: 21544488
[TBL] [Abstract][Full Text] [Related]
22. Specific expression of HSP27 in human tumor cell lines in vitro.
Morino M; Tsuzuki T; Ishikawa Y; Shirakami T; Yoshimura M; Kiyosuke Y; Matsunaga K; Yoshikumi C; Saijo N
In Vivo; 1997; 11(2):179-84. PubMed ID: 9179613
[TBL] [Abstract][Full Text] [Related]
23. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer.
Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R
Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704
[TBL] [Abstract][Full Text] [Related]
24. The effect of heat shock, cisplatin, etoposide and quercetin on Hsp27 expression in human normal and tumour cells.
Jakubowicz-Gil J; Paduch R; Gawron A; Kandefer-Szerszeń M
Folia Histochem Cytobiol; 2002; 40(1):31-5. PubMed ID: 11885806
[TBL] [Abstract][Full Text] [Related]
25. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermia effects on Hsp27 and Hsp72 associations with mismatch repair (MMR) proteins and cisplatin toxicity in MMR-deficient/proficient colon cancer cell lines.
Sottile ML; Losinno AD; Fanelli MA; Cuello-Carrión FD; Montt-Guevara MM; Vargas-Roig LM; Nadin SB
Int J Hyperthermia; 2015; 31(5):464-75. PubMed ID: 26043026
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 27 was up-regulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance.
Yamamoto K; Okamoto A; Isonishi S; Ochiai K; Ohtake Y
Cancer Lett; 2001 Jul; 168(2):173-81. PubMed ID: 11403922
[TBL] [Abstract][Full Text] [Related]
28. Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.
Groen HJ; Sleijfer S; Meijer C; Kampinga HH; Konings AW; De Vries EG; Mulder NH
Br J Cancer; 1995 Dec; 72(6):1406-11. PubMed ID: 8519652
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of heat shock protein 27-mediated resistance to DNA damaging agents by a novel PKC delta-V5 heptapeptide.
Kim EH; Lee HJ; Lee DH; Bae S; Soh JW; Jeoung D; Kim J; Cho CK; Lee YJ; Lee YS
Cancer Res; 2007 Jul; 67(13):6333-41. PubMed ID: 17616692
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of expression levels of bax, bcl-2, and survivin in cancer cells during cisplatin treatment.
Ikeguchi M; Nakamura S; Kaibara N
Oncol Rep; 2002; 9(5):1121-6. PubMed ID: 12168083
[TBL] [Abstract][Full Text] [Related]
31. Heat shock protein expression in canine malignant mammary tumours.
Romanucci M; Marinelli A; Sarli G; Della Salda L
BMC Cancer; 2006 Jun; 6():171. PubMed ID: 16803633
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline.
Hettinga JV; Lemstra W; Meijer C; Mulder NH; Konings AW; de Vries EG; Kampinga HH
Int J Hyperthermia; 1994; 10(6):795-805. PubMed ID: 7884239
[TBL] [Abstract][Full Text] [Related]
33. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma downregulates Hsp27 expression and suppresses the negative regulation of cell death in oral squamous cell carcinoma lines.
Yonekura N; Yokota S; Yonekura K; Dehari H; Arata S; Kohama G; Fujii N
Cell Death Differ; 2003 Mar; 10(3):313-22. PubMed ID: 12700631
[TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
36. Expression of HSP27 results in increased sensitivity to tumor necrosis factor, etoposide, and H2O2 in an oxidative stress-resistant cell line.
Mairesse N; Bernaert D; Del Bino G; Horman S; Mosselmans R; Robaye B; Galand P
J Cell Physiol; 1998 Dec; 177(4):606-17. PubMed ID: 10092213
[TBL] [Abstract][Full Text] [Related]
37. Heat shock proteins and cell proliferation in human breast cancer biopsy samples.
Vargas-Roig LM; Fanelli MA; López LA; Gago FE; Tello O; Aznar JC; Ciocca DR
Cancer Detect Prev; 1997; 21(5):441-51. PubMed ID: 9307847
[TBL] [Abstract][Full Text] [Related]
38. Akt is the downstream target of GRP78 in mediating cisplatin resistance in ER stress-tolerant human lung cancer cells.
Lin Y; Wang Z; Liu L; Chen L
Lung Cancer; 2011 Mar; 71(3):291-7. PubMed ID: 20599289
[TBL] [Abstract][Full Text] [Related]
39. Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance.
Brozovic A; Fritz G; Christmann M; Zisowsky J; Jaehde U; Osmak M; Kaina B
Int J Cancer; 2004 Dec; 112(6):974-85. PubMed ID: 15386344
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines.
Yamada M; Tomida A; Yoshikawa H; Taketani Y; Tsuruo T
Cancer Chemother Pharmacol; 1997; 40(1):31-7. PubMed ID: 9137526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
